Zynerba Pharma (ZYNE) Reports Q2 Loss of $0.70/Share
Tweet
Share
E-mailGet Alerts ZYNE Hot Sheet
Join SI Premium – FREE
Zynerba Pharma (NASDAQ: ZYNE) reported Q2 EPS of ($0.70), versus ($1.12) reported last year.
For earnings history and earnings-related data on Zynerba Pharma (ZYNE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- HawkEye 360 wins NRO contract for commercial RF data services
- Noble Capital Starts Xerox (XRX) at Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
